Ivan Blokhin

Dr. Ivan Blokhin

Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
SMSergey Morozov
Sergey Morozov
AAAnna Andreychenko
Anna Andreychenko
NPNikolay Pavlov
Nikolay Pavlov
AVAnton Vladzymyrskyy
Anton Vladzymyrskyy
NLNatalya Ledikhova
Natalya Ledikhova
VBVladimir Babkin
Vladimir Babkin
This dataset contains anonymised human lung computed tomography (CT) scans with COVID-19 related findings, as well as without such findings. A small subset of studies has been annotated with binary pixel masks depicting regions of interests (ground-glass opacifications and consolidations). CT scans were obtained between 1st of March, 2020 and 25th of April, 2020, and provided by municipal hospitals in Moscow, Russia. Permanent link: https://mosmed.ai/datasets/covid19_1110 . This dataset is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0) License.

30 December 2020 in Digital Diagnostics
Verified
Journal Article
Open access
PDF file
SMSergey Morozov
Sergey Morozov
AAAnna E. Andreychenko
Anna E. Andreychenko
Ivan BlokhinIvan Blokhin
Ivan Blokhin
PGPavel Gelezhe
Pavel Gelezhe
AGAnna P. Gonchar
Anna P. Gonchar
ГАГомболевский Виктор Александрович
Гомболевский Виктор Александрович
With the ongoing COVID-19 pandemic decreasing availability of polymerase chain reaction with reverse transcription and the snowballing growth of medical imaging, especially the number of chest computed tomography (CT) scans being performed, methods to augment and automate the image analysis, increasing productivity and minimizing human error are of particular importance. The creation of high-quality datasets is essential for the development and validation of artificial intelligence algorithms. Such technologies have sufficient accuracy in diagnosing COVID-19 in medical imaging. The presented large-scale dataset contains anonymized human CT scans with COVID-19 features as well as normal studies. Some studies were tagged by radiologists using binary pixel masks of regions of interest (e.g., characteristic areas of consolidation and ground-glass opacities). CT data were acquired between March 1, 2020, and April 25, 2020, and provided by municipal hospitals in Moscow, Russia. The presented dataset is licensed under Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0).

16 December 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
MKMaria R. Kodenko
Maria R. Kodenko
YVYuriy Vasilev
Yuriy Vasilev
AVAnton Vladzymyrskyy
Anton Vladzymyrskyy
OOOlga Omelyanskaya
Olga Omelyanskaya
Denis LeonovDenis Leonov
Denis Leonov
RRRoman V. Reshetnikov
Roman V. Reshetnikov
In this review, we focused on the applicability of artificial intelligence (AI) for opportunistic abdominal aortic aneurysm (AAA) detection in computed tomography (CT). We used the academic search system PubMed as the primary source for the literature search and Google Scholar as a supplementary source of evidence. We searched through 2 February 2022. All studies on automated AAA detection or segmentation in noncontrast abdominal CT were included. For bias assessment, we developed and used an adapted version of the QUADAS-2 checklist. We included eight studies with 355 cases, of which 273 (77%) contained AAA. The highest risk of bias and level of applicability concerns were observed for the “patient selection” domain, due to the 100% pathology rate in the majority (75%) of the studies. The mean sensitivity value was 95% (95% CI 100–87%), the mean specificity value was 96.6% (95% CI 100–75.7%), and the mean accuracy value was 95.2% (95% CI 100–54.5%). Half of the included studies performed diagnostic accuracy estimation, with only one study having data on all diagnostic accuracy metrics. Therefore, we conducted a narrative synthesis. Our findings indicate high study heterogeneity, requiring further research with balanced noncontrast CT datasets and adherence to reporting standards in order to validate the high sensitivity value obtained.

10 July 2020 in Tuberculosis and Lung Diseases
Verified
Journal Article
Open access
PDF file
SMSergey Morozov
Sergey Morozov
Victor GombolevskiyVictor Gombolevskiy
Victor Gombolevskiy
VCValeria Chernina
Valeria Chernina
Ivan BlokhinIvan Blokhin
Ivan Blokhin
OMOlesya Mokienko
Olesya Mokienko
ENE. L. Nikonov
E. L. Nikonov
The objective: to predict lethal outcomes in patients with COVID-19 based on the result of chest computed tomography (chest CT) using a semi-quantitative visual scale of the pulmonary parenchyma lesion.Subjects and methods. Inclusion criteria: patients who underwent chest CT from March 2 to May 1, 2020, inclusively, upon referral of a general practitioner due to suspected community-acquired pneumonia caused by COVID-19. Chest CT was performed in 48 medical organizations providing primary medical care to the adult population in Moscow. Exclusion criteria: patients whose chest CT was not assessed by CT 0-4 score; patients who were not confirmed as COVID-19 positive.In the Russian Federation, CT 0-4 score is recommended to be used for assessment of the extent of lung parenchyma lesion in cases with suspected COVID-19.Data on fatal outcomes were received on May 4, 2020 inclusive.Results: data of 13,003 patients from the Unified Radiological Information Service were retrospectively included in the study according to inclusion and exclusion criteria. The test aimed to detect a trend of directional changes in the proportion of deceased patients among various categories using CT 0-4 score demonstrated a statistically significant result (p < 0.0001). The chance of a lethal outcome increases directionally from CT-0 to CT-4. The test for deviations from the linear trend also provided p < 0.0001, i.e. when moving to higher scores (CT-3 and CT-4), there was an accelerated increase in the risk of death. Analysis of overall survival using the Cox regression model showed that the assessed factors (age and CT 0-4 score) were statistically significantly associated with the time to death from COVID-19 (p < 0.05). The risk of death increased with age, on average, 8.6% for every 5 years (95% CI 0.8-17.0%). When transferring from one category of CT to the next one, the risk increased by 38% on the average (95% CI 17.1-62.6%). There was no statistically significant association of gender factor with overall survival (p = 0.408).The visual score of CT 0-4 recommended for use in the Russian Federation to assess lung parenchyma lesions according to chest CT data, is a predictor of a lethal outcome in patients with COVID-19. CT 0-4 score is convenient for practical use.

30 July 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
YVYuriy Vasilev
Yuriy Vasilev
Ivan BlokhinIvan Blokhin
Ivan Blokhin
AKAnna N. Khoruzhaya
Anna N. Khoruzhaya
MKMaria R. Kodenko
Maria R. Kodenko
VKVasiliy Kolyshenkov
Vasiliy Kolyshenkov
RRRoman Reshetnikov
Roman Reshetnikov
Rationale and Objectives: Post-COVID condition (PCC) is associated with long-term neuropsychiatric symptoms. Magnetic resonance imaging (MRI) in PCC examines the brain metabolism, connectivity, and morphometry. Such techniques are not easily available in routine practice. We conducted a scoping review to determine what is known about the routine MRI findings in PCC patients. Materials and Methods: The PubMed database was searched up to 11 April 2023. We included cohort, cross-sectional, and before–after studies in English. Articles with only advanced MRI sequences (DTI, fMRI, VBM, PWI, ASL), preprints, and case reports were excluded. The National Heart, Lung, and Blood Institute and PRISMA Extension tools were used for quality assurance. Results: A total of 7 citations out of 167 were included. The total sample size was 451 patients (average age 51 ± 8 years; 67% female). Five studies followed a single recovering cohort, while two studies compared findings between two severity groups. The MRI findings were perivascular spaces (47%), microbleeds (27%) and white matter lesions (10%). All the studies agreed that PCC manifestations are not associated with specific MRI findings. Conclusion: The results of the included studies are heterogeneous due to the low agreement on the types of MRI abnormalities in PCC. Our findings indicate that the routine brain MRI protocol has little value for long COVID diagnostics.

16 April 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
YVYuriy Vasilev
Yuriy Vasilev
AVAnton Vladzymyrskyy
Anton Vladzymyrskyy
OOOlga Omelyanskaya
Olga Omelyanskaya
Ivan BlokhinIvan Blokhin
Ivan Blokhin
YKYury Kirpichev
Yury Kirpichev
KAKirill Arzamasov
Kirill Arzamasov
We performed a multicenter external evaluation of the practical and clinical efficacy of a commercial AI algorithm for chest X-ray (CXR) analysis (Lunit INSIGHT CXR). A retrospective evaluation was performed with a multi-reader study. For a prospective evaluation, the AI model was run on CXR studies; the results were compared to the reports of 226 radiologists. In the multi-reader study, the area under the curve (AUC), sensitivity, and specificity of the AI were 0.94 (CI95%: 0.87–1.0), 0.9 (CI95%: 0.79–1.0), and 0.89 (CI95%: 0.79–0.98); the AUC, sensitivity, and specificity of the radiologists were 0.97 (CI95%: 0.94–1.0), 0.9 (CI95%: 0.79–1.0), and 0.95 (CI95%: 0.89–1.0). In most regions of the ROC curve, the AI performed a little worse or at the same level as an average human reader. The McNemar test showed no statistically significant differences between AI and radiologists. In the prospective study with 4752 cases, the AUC, sensitivity, and specificity of the AI were 0.84 (CI95%: 0.82–0.86), 0.77 (CI95%: 0.73–0.80), and 0.81 (CI95%: 0.80–0.82). Lower accuracy values obtained during the prospective validation were mainly associated with false-positive findings considered by experts to be clinically insignificant and the false-negative omission of human-reported “opacity”, “nodule”, and calcification. In a large-scale prospective validation of the commercial AI algorithm in clinical practice, lower sensitivity and specificity values were obtained compared to the prior retrospective evaluation of the data of the same population.